GB201808571D0 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
GB201808571D0
GB201808571D0 GBGB1808571.2A GB201808571A GB201808571D0 GB 201808571 D0 GB201808571 D0 GB 201808571D0 GB 201808571 A GB201808571 A GB 201808571A GB 201808571 D0 GB201808571 D0 GB 201808571D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1808571.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Douglas Pharmaceuticals Ltd
Original Assignee
Douglas Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Douglas Pharmaceuticals Ltd filed Critical Douglas Pharmaceuticals Ltd
Priority to GBGB1808571.2A priority Critical patent/GB201808571D0/en
Publication of GB201808571D0 publication Critical patent/GB201808571D0/en
Priority to PCT/IB2019/054290 priority patent/WO2019224777A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB1808571.2A 2018-05-24 2018-05-24 Pharmaceutical compositions Ceased GB201808571D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1808571.2A GB201808571D0 (en) 2018-05-24 2018-05-24 Pharmaceutical compositions
PCT/IB2019/054290 WO2019224777A1 (en) 2018-05-24 2019-05-23 Pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1808571.2A GB201808571D0 (en) 2018-05-24 2018-05-24 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
GB201808571D0 true GB201808571D0 (en) 2018-07-11

Family

ID=62812398

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1808571.2A Ceased GB201808571D0 (en) 2018-05-24 2018-05-24 Pharmaceutical compositions

Country Status (2)

Country Link
GB (1) GB201808571D0 (en)
WO (1) WO2019224777A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201808564D0 (en) 2018-05-24 2018-07-11 Douglas Pharmaceuticals Ltd Treatments
GB201917252D0 (en) * 2019-11-27 2020-01-08 Pharmaceutic compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4701471A (en) * 1986-04-16 1987-10-20 Loucks Sr Joseph Skin care composition
AU2003289329A1 (en) * 2002-12-13 2004-07-09 Ono Pharmaceutical Co., Ltd. Antagonist and agonist binding to strong binding site of chemokine receptor
US8372430B2 (en) * 2002-12-17 2013-02-12 The Procter & Gamble Company Compositions, methods, and kits useful for the alleviation of gastrointestinal effects
HUE026911T2 (en) * 2009-06-11 2016-07-28 Photocure Asa Semi-solid compositions and pharmaceutical products
WO2014131919A1 (en) * 2013-02-28 2014-09-04 Jimeno Martínez Leonardo Product for topical use on the scalp and method for producing same
JP6424815B2 (en) * 2013-04-11 2018-11-21 大正製薬株式会社 Composition for external use
AU2014338707B2 (en) 2013-10-23 2020-06-04 The University Of Manchester Treatment of cancer and benign proliferative disorders
US20170087199A1 (en) * 2016-02-10 2017-03-30 Senomyx, Inc. Compositions for delivering a cooling sensation

Also Published As

Publication number Publication date
WO2019224777A1 (en) 2019-11-28

Similar Documents

Publication Publication Date Title
IL271657A (en) Pharmaceutical compositions
IL271759B1 (en) Pharmaceutical compositions comprising entrectinib
GB201804548D0 (en) Pharmaceutical compositions
GB201705303D0 (en) Pharmaceutical compositions
SG11202001179YA (en) Pharmaceutical compositions
GB201911517D0 (en) Pharmaceutical composition
GB201705305D0 (en) Pharmaceutical compositions
GB201807053D0 (en) Pharmaceutical composition
GB201705304D0 (en) Pharmaceutical compositions
GB201705306D0 (en) Pharmaceutical compositions
SG11202103374TA (en) Pharmaceutical composition
GB201808571D0 (en) Pharmaceutical compositions
EP3727485C0 (en) Pharmaceutical composition
IL272044A (en) Pharmaceutical compositions
SG11202110315SA (en) Pharmaceutical composition
PL3908321T3 (en) Pharmaceutical composition
GB201808567D0 (en) Pharmaceutical compositions
GB201810109D0 (en) Pharmaceutical compositions
ZA202006541B (en) Pharmaceutical composition comprising brexpiprazole
IL272428A (en) Pharmaceutical compositions
GB201810265D0 (en) New pharmaceutical compositions
GB201810261D0 (en) New pharmaceutical compositions
ZA202000014B (en) Pharmaceutical compositions
GB201820689D0 (en) Pharmaceutical composition
IL285728A (en) Pharmaceutical composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)